OpenAlex
PricingAboutJobs
Log inGet started
Work

Safety, Efficacy, and Pharmacokinetics of TBR-652, a CCR5/CCR2 Antagonist, in HIV-1–Infected, Treatment-Experienced, CCR5 Antagonist–Naive Subjects

HTML

Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: JAIDS Journal of Acquired Immune Deficiency Syndromes
DOI: 10.1097/qai.0b013e318213c2c0
Authors: Jacob Lalezari, Joseph Gathe, Cynthia Brinson, Melanie Thompson, Calvin Cohen, Edwin Dejesus, Jorge Galindez, Jerome A Ernst, David E Martin, Sandra M Palleja
Institution: Quest Clinical Research (United States)
Language: English

Topic: HIV/AIDS drug development and treatment
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: CCR5 antagonist, CCR2 antagonist, HIV-1 infection, antiretroviral-naive patients, treatment-experienced patients, HIV-1 RNA suppression, CD4 count, MCP-1, C-reactive protein, interleukin-6, pharmacokinetics, pharmacodynamics, safety and tolerability, oral antiretroviral therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2069953817
FWCI: 5.168
Cites: 21
Cited by: 66
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security